Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.dolphinmedicalservices.com | |
Market Cap | 4.03 Cr. | |
Enterprise Value(EV) | 4.77 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.04 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 6.76 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.40 | Calculated using Price: 2.67 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.51 Cr. | 15,099,952 Shares |
FaceValue | 10 | |
About Dolphin Medical Services Ltd. | ||
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists. |
1 Day |
|
|
1 Week |
|
-4.98% |
1 Month |
|
-10.40% |
3 Month |
|
+36.22% |
6 Month |
|
+44.32% |
1 Year |
|
+70.06% |
2 Year |
|
+27.75% |
5 Year |
|
+210.47% |
10 Year |
|
+130.17% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -4.39 | -0.36 | -2.12 | -2.41 | -8.6 | -3.5 | -2.93 | -1.8 | -1.22 | |
Return on Capital Employed (%) | -2.56 | -0.06 | -1.43 | -1.57 | -5.38 | -2.07 | -2.01 | -1.5 | -0.98 | |
Return on Assets (%) | -2.62 | -0.21 | -1.25 | -1.41 | -5.15 | -2.15 | -2.07 | -1.53 | -1.02 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 13 | 13 | 12 | 12 | 11 | 11 | 10 | 10 | 10 | 10 | |
Non Curr. Liab. | 9 | 9 | 9 | 9 | 7 | 7 | 1 | 1 | 1 | 1 | |
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 22 | 22 | 21 | 21 | 18 | 18 | 12 | 12 | 12 | 12 | |
Non Curr. Assets | 20 | 20 | 19 | 19 | 16 | 16 | 10 | 10 | 10 | 10 | |
Curr. Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 22 | 22 | 21 | 21 | 18 | 18 | 12 | 12 | 12 | 12 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | |
Total Income | 0 | 1 | 0 | 0 | 0 | 0 | 6 | 1 | 1 | 1 | |
Total Expenditure | 0 | 0 | 0 | 0 | -1 | -1 | -6 | -1 | -1 | -1 | |
PBIDT | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | ||
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 2 | 0 | ||||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | ||||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Thu, 28 Mar 2024
Closure of Trading Window Closure of Trading Window |
Wed, 14 Feb 2024
Unaudited Financial Results For The Quarter Ended 31.12.2023 Unaudited Financial Results for the Quarter ended 31.12.2023 |
Sat, 03 Feb 2024
Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter Ended 31.12.2023 DOLPHIN MEDICAL SERVICES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited financial results for the Quarter ended 31.12.2023 |
Tue, 26 Mar 2024 |
Close Crossing Last Week Low |
Opening at High |
Opening at Low |
Closing Below Previous Low |
Close Below Last Week Low |